Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-16 Purchase |
2023-11-16 4:37 pm |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
20,000 | $2.46 | $49,200 | 527,114 (Direct) |
View |
| 2023-06-23 Purchase |
2023-06-26 4:14 pm |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
38,364 | $3.91 | $150,003 | 507,114 (Direct) |
View |
| 2023-04-10 Purchase |
2023-04-11 5:40 pm |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
468,750 | $1.6 | $750,000 | 608,750 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-01 Option Award |
2024-06-03 5:06 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
130,000 | $0 | 657,114 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-11 5:40 pm |
N/A 2033-04-09 |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
140,000 | $0 | 608,750 (Direct) |
View |